PharmaVoice 100: Page 4
-
Permission granted by Dr. Helen Thackray
Profile // PharmaVoice 100Legacy Leaders: Dr. Helen Thackray
The chief research and development officer at BioCryst Pharmaceuticals is leaning into decades of experience to advance a promising pipeline of rare disease products.
By PharmaVoice staff • Sept. 6, 2022 -
Permission granted by Henrietta Ukwu
Profile // PharmaVoice 100Legacy Leaders: Dr. Henrietta Ukwu
Novavax’s regulatory head helped the company pull off its first approvals with the FDA and the EMA — but her accomplishments in pharma run deep.
By Meagan Parrish • Sept. 6, 2022 -
Permission granted by Houda Hachad
Profile // PharmaVoice 100Tech Wizards: Houda Hachad
This inventor and ‘entrepreneurial scientist’ is developing new technologies to manage data and use insights from genomic testing at AccessDx Laboratory.
By Alexandra Pecci • Sept. 6, 2022 -
Permission granted by Ian Walters
Profile // PharmaVoice 100Disrupters: Dr. Ian Walters
How the CEO of Portage Biotech is steering cancer R&D in a new direction by advancing diverse drug platforms.
By PharmaVoice staff • Sept. 6, 2022 -
Permission granted by Dr. Jane Barlow
Profile // PharmaVoice 100Disrupters: Dr. Jane Barlow
The executive vice president and chief clinical officer of Real Endpoints is boosting patient access to innovative therapies through value-based payer agreements.
By Meagan Parrish • Sept. 6, 2022 -
Permission granted by Jeanne Magram
Profile // PharmaVoice 100Innovators: Jeanne Magram
Celsius Therapeutics’ CSO is turning ideas into approved medicines for patients with cancer and autoimmune diseases.
By PharmaVoice staff • Sept. 6, 2022 -
Permission granted by Jeff Fischer
Profile // PharmaVoice 100Entrepreneurs: Jeff Fischer
The co-founder and president led Longhorn Vaccines and Diagnostics to an unprecedented surge in production of its testing tech at the height of COVID-19 and is now pursuing a universal flu vaccine.
By Karissa Waddick • Sept. 6, 2022 -
Permission granted by Jennifer Gottlieb
Profile // PharmaVoice 100DE&I Champions: Jennifer Gottlieb
The global president and chief client officer of Real Chemistry is dedicated to ensuring all voices at the agency are heard and everyone has a seat at the table.
By PharmaVoice staff • Sept. 6, 2022 -
Permission granted by Jennifer Gould
Profile // PharmaVoice 100Disrupters: Jennifer Gould
How the director of marketing excellence at GSK is helping usher in a new era of pharma marketing and patient personalization with a collaborative cross-industry approach.
By Karissa Waddick • Sept. 6, 2022 -
Permission granted by Jennifer Kelly
Profile // PharmaVoice 100Tech Wizards: Jennifer Kelly
The president of patient experience is helping transform clinical trials with an innovative platform.
By Meagan Parrish • Sept. 6, 2022 -
Permission granted by Dr. Jeremy Levin
Profile // PharmaVoice 100Legacy Leaders: Dr. Jeremy Levin
Over his 30-year career, the founder, chairman and CEO of Ovid Therapeutics has demonstrated that he is a patient advocate, scientist, clinician and innovator at heart.
By PharmaVoice staff • Sept. 6, 2022 -
Permission granted by Jim Anthony
Profile // PharmaVoice 100Disrupters: Jim Anthony
With a ready-for-anything attitude and a knack for relationship-building, the executive vice president and global head of Parexel Biotech is growing the CRO with a patient-first approach.
By PharmaVoice staff • Sept. 6, 2022 -
Permission granted by Jim Doherty
Profile // PharmaVoice 100Innovators: Jim Doherty
Sage Therapeutics’ chief development officer is leveraging innovative development strategies to create success against hard-to-treat brain disorders.
By Meagan Parrish • Sept. 6, 2022 -
Permission granted by John Oyler
Profile // PharmaVoice 100Entrepreneurs: John Oyler
The CEO of BeiGene is using innovative business strategies to help the oncology biotech quickly hit new heights.
By Meagan Parrish • Sept. 6, 2022 -
Permission granted by John Tsai
Profile // PharmaVoice 100Innovators: Dr. John Tsai
How the former president of global drug development and chief medical officer at Novartis funneled his curiosity for engineering into a bold new approach to drug development.
By Meagan Parrish • Sept. 6, 2022 -
Permission granted by Johnna Wesley
Profile // PharmaVoice 100Innovators: Johnna Wesley
The vice president of Type 1 diabetes and kidney disease research at Novo Nordisk is leading the charge to deliver paradigm-changing breakthroughs in the space.
By PharmaVoice staff • Sept. 6, 2022 -
Permission granted by Dr. Jonathan Ng
Profile // PharmaVoice 100Tech Wizards: Dr. Jonathan Ng
As CEO of Iterative Scopes, Dr. Jonathan Ng is relentlessly committed to health equity while leveraging AI to establish new standards of care for detection and treatment of GI diseases.
By PharmaVoice staff • Sept. 6, 2022 -
Permission granted by Jonathan Steckbeck
Profile // PharmaVoice 100Disrupters: Jonathan Steckbeck
The CEO, founder and president of Peptilogics is changing the game for the peptide medicine space with a promising pipeline and a disruptive discovery platform.
By Meagan Parrish • Sept. 6, 2022 -
Permission granted by Dr. Jordan Schecter
Profile // PharmaVoice 100Innovators: Dr. Jordan Schecter
The VP of cellular therapy at Janssen has used collaboration, creative thinking and pragmatism to create a CAR-T multiple myeloma breakthrough.
By PharmaVoice staff • Sept. 6, 2022 -
Permission granted by Julie Kim
Profile // PharmaVoice 100Disrupters: Julie Kim
The president of Takeda’s U.S. business unit and U.S. country head has steered through the pandemic, turning her aptitude for bringing people together into a master class in perseverance.
By Michael Gibney • Sept. 6, 2022 -
Permission granted by Karin Jooss
Profile // PharmaVoice 100Innovators: Karin Jooss
The EVP and head of R&D at Gritstone bio is using her decades as a visionary drug developer to help the company advance vaccines for cancer.
By Meagan Parrish • Sept. 6, 2022 -
Permission granted by Kathy Lee-Sepsick
Profile // PharmaVoice 100Entrepreneurs: Kathy Lee-Sepsick
Kathy Lee-Sepsick, the founder of Femasys, is determined to change the game in long-neglected areas of women’s healthcare, some of which haven’t had much innovation in more than a century.
By Alexandra Pecci • Sept. 6, 2022 -
Permission granted by Everest Medicines
Profile // PharmaVoice 100Legacy Leaders: Dr. Kerry Blanchard
The former CEO of Everest Medicines has focused on breaking new ground for China-based innovation.
By PharmaVoice staff • Sept. 6, 2022 -
Permission granted by Kim Johnson
Profile // PharmaVoice 100Legacy Leaders: Kim Johnson
The Global CEO is breathing fresh air into Ogilvy Health as she blazes a new trail at the storied agency.
By Alexandra Pecci • Sept. 6, 2022 -
Permission granted by Kuldeep Singh Rajput
Profile // PharmaVoice 100Entrepreneurs: Kuldeep Singh Rajput
Bringing digital solutions to Big Pharmas adapting to a more patient-centric age, the CEO and founder of Biofourmis has instituted a flexible approach that keeps its tech on the leading edge.
By Michael Gibney • Sept. 6, 2022
Previous
